http://www.chemocentryx.com
ChemoCentryx, Inc. Company Intro
Positive topline data from pivotal Phase III ADVOCATE trial demonstrates avacopan’s superiority over standard of care in ANCA-associated vasculitis.
Industry
Healthcare
ChemoCentryx, Inc. Headquaters
850 Maude Avenue
Mountain View,94043
United States
ChemoCentryx, Inc. Share price
28 Oct 2020 01:18 GMT
$53.03
-0.17 (-0.32 %)
ChemoCentryx, Inc. Market cap
$3.612 B
WMC RANKING
2020
ChemoCentryx, Inc. # 69
BiotechnologyLatest ChemoCentryx, Inc. News
28 Oct 2020
Anca Vasculitis Drug Market Size 2020 By Product Types, End-Users, Regional Outlook, Growth, Trends And Forecast To 2027 | Market Research Intellect
ChemoCentryx; Inc. GlaxoSmithKline plc; Kineta; Inc. In Market Segmentation by Anca Vasculitis Drug Types, the report includes: Belimumab; Ccx-1378; Ccx- ...
28 Oct 2020
CC Chemokine Receptor Type 4 Market Size 2020 By Product Types, End-Users, Regional Outlook, Growth, Trends And Forecast To 2027 | Market Research Intellect
ChemoCentryx Inc; Corion Biotech Srl; FLX Bio Inc; Globavir Biosciences Inc; Kyowa Hakko Kirin Co Ltd; Ono Pharmaceutical Co Ltd. In Market Segmentation by ...
28 Oct 2020
Atypical Chemokine Receptor 3 Market Size 2020 By Product Types, End-Users, Regional Outlook, Growth, Trends And Forecast To 2027 | Market Research Intellect
ChemoCentryx Inc; Jyant Technologies Inc; Polyphor Ltd. In Market Segmentation by Atypical Chemokine Receptor 3 Types, the report includes: CCX-650; JT- ...
WMC Market Score
WMC Market to Revenue Score
ChemoCentryx, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| ChemoCentryx, Inc. | USD | $75,590 | $107,081 | $-29,810 | $3.612B | 69 |
| Alexion Pharmaceuticals, Inc. | USD | $5,536,800 | $2,523,000 | $846,100 | $26.301B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $5,402,685 | $2,634,428 | $2,080,775 | $55.268B | 2 |
| 3SBio Inc. | CNY | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.039B | 3 |
| Incyte Corporation | USD | $2,229,409 | $1,622,822 | $446,906 | $19.322B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total ChemoCentryx, Inc. Social Followers vs Top 4 Industry Competitors
ChemoCentryx, Inc. Post vs Top 4 Industry Competitors
ChemoCentryx, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| ChemoCentryx, Inc. | 1.37 | 0.35 | 0.96 | 0 | 0 | 0 | 0.98 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.35 | 100 | 20 | 0 | 0 | 100 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.32 | 26 | 0 | 0 | 97.49 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 2.78 |
| Incyte Corporation | 40.27 | 14.27 | 7.19 | 100 | 0 | 0 | 90.87 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
